Gallium-67 scintigraphy in lymphoma with bone involvement.
Rachel Bar‐Shalom(Rambam Health Care Campus), Einat Even‐Sapir(Tel Aviv Sourasky Medical Center), Menachem Ben‐Shachar(Rambam Health Care Campus), Nissim Haim(Technion – Israel Institute of Technology), Myriam Ben-Arush, Michelle Leviov(Haifa Medical Center), Ron Epelbaum(University of Bern), Ora Israel(Technion – Israel Institute of Technology), Diana Gaitini(Technion – Israel Institute of Technology), Simona Ben‐Haim(Investigators Research Group (United States))
PubMed
March 1, 1995
Cited by 27
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279